Weiwei Kong
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 6
- Nephrology top 10%
- Polymers and Plastics top 10%
- Polymer composites and self-healing 5
- Hepatology top 10%
-
- Pancreatic and Hepatic Oncology Research 12
- Cancer Immunotherapy and Biomarkers 7
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
-
- Gastric Cancer Management and Outcomes 4
-
- Neuroendocrine Tumor Research Advances 4
-
- Viral Infectious Diseases and Gene Expression in Insects 4
- Co-authors
- Dong ChenPeng QuWenli XieDing‐Xiang YanKun DaiTing WangJiefeng GaoZhong‐Ming Li
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiwei Kong
65 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 123
- Cancer Research 185
- Nephrology 58
- Polymers and Plastics 103
- Immunology 155
- Hepatology 58
Countries citing papers authored by Weiwei Kong
This map shows the geographic impact of Weiwei Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Kong more than expected).
Fields of papers citing papers by Weiwei Kong
This network shows the impact of papers produced by Weiwei Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Kong. The network helps show where Weiwei Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiwei Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 0 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 109 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 41 | |
| 16 | 2019 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2017 | 80 | |
| 19 | 2015 | 20 | |
| 20 | 2011 | 10 |
About Weiwei Kong
Weiwei Kong is a scholar working on Cancer Research, Transplantation and Oncology, having authored 75 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (12 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Genomics and Diagnostics (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Polymer composites and self-healing (5 papers), Gastric Cancer Management and Outcomes (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). The work is most often cited by research in Cancer Research (185 citations), Nephrology (58 citations) and Polymers and Plastics (103 citations). Weiwei Kong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dong Chen, Peng Qu, Wenli Xie, Ding‐Xiang Yan, Kun Dai, Ting Wang, Jiefeng Gao, Zhong‐Ming Li, Wan-Cheng Yu and Congcong Jiao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.